# Winship Cancer Institute Cancer Center Support Grant

> **NIH NIH P30** · EMORY UNIVERSITY · 2021 · $60,000

## Abstract

PROJECT SUMMARY/ABSTRACT - Cancer Clinical Investigator Team Leadership Award (CCITLA)
Dr. Eaton is an academic radiation oncologist with a research focus on therapeutic clinical trial development
involving novel approaches of radiotherapy for pediatric and adult brain tumor patients. Her goal is to lead
institutional investigator-initiated and NCI-funded cooperative group clinical trials that will further advance the
fight against cancer. Dr. Eaton plays a critical role in Winship Cancer Institute's clinical trial program and is
extensively involved in NCI funded clinical trials. She is as an active member in multiple national committees of
NRG Oncology and the Children's Oncology Group (COG), and the Pediatric Brain Tumor Consortium (PBTC).
She is the institutional principal investigator of two NCI-funded clinical trials through NRG Oncology and five
investigator initiated clinical trials at Winship, and contributes as an active co-investigator on numerous others.
As a radiation oncology leader among the Winship brain tumor pediatric oncology programs, Dr. Eaton is an
important contributor to patient enrolment to NCTN trials at Winship, playing a major role in the Winship Lead
Academic Participating Site (LAPS award) award from the NCI. She is an integral member of Winship's Clinical
and translational Research Committee (CTRC) and serves as the Pediatric Medical Director of the Emory
Proton Therapy Center (EPTC), which opened in 2018 as the first proton center in the state of Georgia. In this
role, Dr. Eaton led the EPTC Imaging and Radiation Oncology Core (IROC) credentialing process necessary
for participation in NCTN clinical trials, critical to the successful opening of 12 NCI funded clinical trials at
EPTC and supporting NCTN clinical trial accrual with the adoption of this advanced technology in the state of
Georgia. Winship Cancer Institute of Emory University fully supports Dr. Eaton in her career goals to advance
as a national leader in clinical trials for brain tumor patients and pediatric malignancies, and in her ongoing
efforts to enhance the clinical trial program at Winship. The CCITLA award will support protected time for Dr.
Eaton to focus on key initiatives that will develop infrastructure and process improvements to expand clinical
trials and increase trial accrual at Winship, and further develop her own promising protocol concepts at the
national level. The CCITLA funding mechanism will undoubtedly help foster academic growth and lead to
further leadership roles within the Department of Radiation Oncology, Winship Cancer Institute, Emory
University, as well as the NCI Trial Networks.

## Key facts

- **NIH application ID:** 10328151
- **Project number:** 3P30CA138292-13S1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Adam I. Marcus
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $60,000
- **Award type:** 3
- **Project period:** 2009-04-07 → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10328151

## Citation

> US National Institutes of Health, RePORTER application 10328151, Winship Cancer Institute Cancer Center Support Grant (3P30CA138292-13S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10328151. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*